Apply by 3/23: Boardroom Lunch with former Dow CEO
Featured Events | Mar 11, 2014 | Claire Curry
Apply by March 23 for a seat at this Boardroom Lunch with Fordham alumnus William Stavropoulos, former CEO and chairman of The Dow Chemical Company. Learn about his 39-year career in positions ranging from research to marketing to general management.
Date of lunch: Tuesday, April 1, 2014
Time: 11:30 a.m. – 12:45 p.m.
Location: Hughes Hall, Room 313
Application deadline: Midnight, March 23, 2014
To be considered, fill out the application form. Students will be selected based on your responses to the questionnaire, and will be notified by e-mail. You must apply by midnight on Sunday, March 23.
About the host:
William S. Stavropoulos
William Stavropoulos, former CEO and chairman, is chairman emeritus of the Board of Directors of The Dow Chemical Company, Midland, Michigan. From 1993 through 2006, he served as president and chief operating officer, CEO and chairman. He was a member of the Board of Directors of Dow from July 1990 to March 2006.
Stavropoulos received many honors throughout his career including: 2010 named an Archon by His All Holiness Ecumenical Patriarch; 2010 inducted into the Midland County Sports Hall of Fame as a “Professional Baseball Visionary, 2007 Northwood University Naegele Distinguished Community Service Award, induction into Junior Achievement of Central Michigan’s Business Hall of Fame in 2005; Northwood University’s 2004 Outstanding Business Leader Award; and Institutional Investor magazine’s award as one of the Best CEOs in America in the category of Chemicals/Commodity.
He is president and founder of the Michigan Baseball Foundation, the Great Lakes Loons. He is on the Advisory Board for Metalmark Capital LLC and is an Advisor to Clayton, Dubilier & Rice, LLC. He is a trustee of the Fidelity Equity and High Income Funds Board and Fidelity Sector Portfolios Board. Stavropoulos is chairman of the board of directors of Univar Inc.
Stavropoulos holds a Bachelor of Science degree from Fordham University and a doctorate in medicinal chemistry from the University of Washington.
